Photo of Brady Hunt

Brady Hunt

Brady focuses his practice on toxic tort litigation, primarily cases involving asbestos, and general litigation. As a Pittsburgh-area native, he’s enthusiastic about the historical research many cases require, and he feels a personal connection to the people, industries, companies, and products that have long been an integral part of his region. Brady serves on both national coordinating counsel teams for multinational corporations as well as local counsel teams handling matters in western Pennsylvania and West Virginia. He plays a key role in day-to-day case management, overseeing dockets and ensuring that client litigation remains on track and within deadlines. Brady regularly attends court, argues motions, participates in depositions, and keeps clients apprised of developments.

Known for his persuasive skills, Brady believes the first step in gaining the confidence of an audience is truly believing in one’s own position. In his career, Brady has achieved notable, at times unexpected, positive results in the courtroom for his clients. Clients also appreciate his diligence and dedication to their cases: Brady takes pride in being on top of even the smallest details, and clients can have confidence their litigation is in good hands.

As discussed in the Product Perspective, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) represents a major shift in cosmetic industry regulations. This article is one of a series of posts diving into each aspect of MoCRA. Here, we will introduce the FDA’s online portal, FDA Direct, and show how it can be used for complying with MoCRA’s Facility Registration and Cosmetic Listing requirements.